Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery
Study Details
Study Description
Brief Summary
Efficacy/Safety of antibiotic steroid combination compared with individual administration in inflammation Post-LASIK
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
antibiotic/steroid combination compared to individuals components 15 days of treatment
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: antibiotic steroid (single vial) efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery |
Drug: antibiotic/steroid combination
1gtt, 4x/d, 15 days
Other Names:
|
Active Comparator: antibiotic / steroid (2 vials) efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery |
Drug: moxifloxacin/dexamethasone
1gtt, 4x/days, 15 days
Other Names:
|
Outcome Measures
Primary Outcome Measures
- day 15 evaluation of anterior chamber [15 days pos-op]
Secondary Outcome Measures
- day 15 evaluation of ocular pain, physician´s follow-up impression of inflammatory reaction score [15 days pos-op]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients having LASIK surgery;
-
men or women of any race, between 18 and 50 years old, presenting up to 8 degrees of myopia or up to 4 degrees of hypermetropia, or up to 3 degrees of astigmatism, without any other associated ocular problems
Exclusion Criteria:
-
Uncontrolled glaucoma or intraocular hypertension;
-
Use of any ocular anti-infectious drugs or any topical or systemic ocular NSAIDs during the study but study drugs;
-
A history of chronic or recurrent ocular inflammatory disease;
-
Uncontrolled diabetes mellitus and diabetic retinopathy ;
-
Patients with sight in a single eye;
-
Iris atrophy in the eye to be operated;
-
Pregnant or lactating women, or women of childbearing potential who are not using proper birth-control methods;
-
Known or suspected allergy or hypersensitivity to any component of study medication;
-
A history or any other evidence of severe systemic disease
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Dept. of Ophthalmology - Rua Botucatu 824 | São paulo | SP | Brazil | 04023-062 |
Sponsors and Collaborators
- Federal University of São Paulo
Investigators
- Principal Investigator: Rubens Belfort Jr, MD, PhD, Federal University of São Paulo
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- BRA-05-02